Symposia

Psychedelics: A Clinical Perspective

 

 

On Tuesday, October 22, 2024, the Association of Cannabinoid Specialists welcomed Eugene Vortsman, DO to present on Psychedelic Medicine: A Clinical Perspective.

While this is a slight departure from our regular programming, ACS feels that with psychedelics on the ballot in states such as Massachusetts in 2024, as well as the increase in research and interest, it is important to provide educational opportunities on such topics.
Dr. Vortsman gave an thought-provoking and fast-paced lectured on several types of psychedelics, how they each work in the body, side effects, studies, what medical benefits we hope to gain from these substances in the future based on the research we are seeing now, and the limitations of that research.

CannaKeys360 Demo

 

Cannakeys360 is a medical literature search engine that presents available studies in unique ways that better support clinicians and researchers than simple PubMed searches.

This video demonstrates their capabilities as presented to the Association of Cannabinoid Specialists membership in March 2022.  ACS members get a 30% discount on their yearly subscription to this service. 


ACS Genetic Testing Symposium

 

This is the video recording of the symposium produced by the Association of Cannabis Specialists to discuss the state of the art and evidence for human genetic testing to guide medical cannabis therapy.


Risks Associated With Cannabis

 

 

On May 21, 2024, ACS was joined by Dr. Eugene Vortsman as he discussed the risks associated with cannabis.


Communicating Cannabis Use Before Surgery

 

 

On June 18, 2024, the Association of Cannabinoid Specialists was proud to host the symposium “Communicating Cannabis Use Before Surgery”, featuring Deondra Asike, MD, double board certified in anesthesiology and pain medicine.  In this symposium, Dr. Asike discusses the risks associated with cannabis use before surgery.


ACS Presents: A Policy Panel on Rescheduling

 

 

On September 24, 2024, the Association of Cannabinoid Specialists hosted a paneled event surrounding the topic of policy and rescheduling, and what it means for patients and clinicians. The format was a paneled discussion featuring three lawyers (Mark Bolton, Bryant Godfrey, and Kristine Blackwood), a cannabinoid physician (Jordan Tishler, MD), and a moderator in front of a live audience reading questions submitted to ACS prior to the event.